Bio Path Holdings Inc (BPTH)

NASDAQ

Currency in USD

0.677

-0.033(-4.66%)

Closed15:59:59

After Hours

0.710+0.033(+4.874%)

19:53:39

Fair Value

Day's Range

0.640

0.756

52 wk Range

0.610

12.000

BPTH Income Statement

Explore the detailed Bio Path Holdings Inc income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Bio Path Holdings Inc's growth trends and overall financial health.

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

-

-

-

-

-

Total Revenues Growth

-

-

-

-

-

Cost Of Revenues

-

-

-

-

-

Gross Profit

-

-

-

-

-

Gross Profit Growth

-

-

-

-

-

Gross Profit Margin %

-

-

-

-

-

Other Operating Expenses, Total

8.69

10.91

10.44

13.9

15.84

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+8.91%	+25.48%	-4.26%	+33.11%	+13.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4.59	6.58	5.91	9.17	11.61
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4.11	4.33	4.53	4.74	4.24
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

-8.69

-10.91

-10.44

-13.9

-15.84

Operating Income Growth

-8.91%

-25.48%

+4.26%

-33.11%

-13.97%

EBIT Margin %

-

-

-

-

-

Net Interest Expenses

0.09

0.03

0

0.03

0.04

Net Interest Expenses Growth

+1,242.86%

-72.34%

-88.46%

+1,000%

+9.09%

Interest Expense, Total

-

-

-

-

-

Interest And Investment Income

0.09

0.03

0

0.03

0.04

Other Non Operating Expenses, Total

-

-

-

-

-0.27

EBT, Excl. Unusual Items

-8.6

-10.88

-10.44

-13.87

-16.08

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-

-

-

-

EBT, Incl. Unusual Items

-8.6

-10.88

-10.44

-13.87

-16.08

EBT, Incl. Unusual Items Growth

-0.19%

-26.55%

+4.06%

-32.84%

-15.94%

EBT, Incl. Unusual Items Margin

-

-

-

-

-

Income Tax Expense

-

-

-

-

-

Net Income to Company

-8.6

-10.88

-10.44

-13.87

-16.08

Minority Interest

-

-

-

-

-

Net Income

-8.6

-10.88

-10.44

-13.87

-16.08

Net Income Growth

-0.19%

-26.55%

+4.06%

-32.84%

-15.94%

Net Income Margin %

-

-

-

-

-

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-8.6

-10.88

-10.44

-13.87

-16.08

Basic EPS - Continuing Operations

-64.73

-56.57

-31.05

-38.1

-33.64

Basic EPS - Continuing Operations Growth

+77.49%

+12.6%

+45.12%

-22.71%

+11.71%

Diluted EPS - Continuing Operations

-64.73

-56.57

-31.05

-38.12

-33.64

Diluted EPS - Continuing Operations Growth

+77.49%

+12.6%

+45.12%

-22.78%

+11.76%

Basic Weighted Average Shares Outstanding

0.13

0.19

0.34

0.36

0.48

Diluted Weighted Average Shares Outstanding

0.13

0.19

0.34

0.36

0.48

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

-8.56

-10.84

-10.37

-13.81

-15.76

EBITDA Growth

-13.27%

-26.6%

+4.33%

-33.24%

-14.1%

EBITDA Margin %